Hyivy Health Company Profile

Background

Hyivy Health, founded in 2020 and headquartered in Kitchener, Ontario, is a FemTech startup dedicated to revolutionizing pelvic health rehabilitation. The company was established by Rachel Bartholomew, who, after her personal battle with cervical cancer, recognized the critical need for innovative solutions in women's pelvic health. Hyivy Health's mission is to provide intelligent, holistic rehabilitation devices for women suffering from pelvic-related cancers and diseases, aiming to enhance their quality of life through advanced technology and comprehensive care.

Key Strategic Focus

Hyivy Health concentrates on developing a multi-therapy pelvic health rehabilitation system that integrates auto-dilation, thermal therapy, and self-lubrication. This system is designed to offer personalized, at-home treatment protocols prescribed by accredited clinicians. By connecting patients with their healthcare providers through a dedicated app and clinician software, Hyivy Health ensures continuous monitoring and adaptation of treatment plans. The primary markets targeted include women experiencing pelvic floor dysfunction, chronic pelvic pain, and those recovering from gynecological and colorectal cancers.

Financials and Funding

Hyivy Health has successfully secured funding to support its innovative endeavors:

Pre-Seed Funding (January 2022): Raised $1.1 million from investors such as Threshold Impact, Beresford Ventures, Equation Angels, Zambon Research Venture, The51, OCI, iGan, Arch Angels, and Velocity.

Seed Funding (September 2024): Secured $2 million in a round led by Zcube – Zambon Research Venture, with participation from Beresford Ventures, FACIT, Women's Equity Lab, and Chai Ventures.

The capital raised is allocated towards advancing clinical trials, obtaining regulatory approvals, and preparing for market entry, particularly focusing on the U.S. market.

Pipeline Development

Hyivy Health is actively engaged in clinical trials to validate its rehabilitation system:

Grand River Hospital Regional Cancer Centre Trial: This study addresses the needs of gynecological and colorectal cancer patients, aiming to improve post-treatment rehabilitation.

McMaster University Trial: Led by Dr. Mathew Leonardi, this trial focuses on endometriosis patients, evaluating the system's effectiveness in managing pelvic pain.

These trials are crucial steps toward obtaining regulatory approvals and demonstrating the system's efficacy in diverse patient populations.

Technological Platform and Innovation

Hyivy Health's rehabilitation system stands out due to its integration of multiple therapeutic modalities and data-driven insights:

Proprietary Technologies: The device combines auto-dilation, thermal therapy (hot and cold contrast), and self-lubrication to provide comprehensive pelvic floor rehabilitation.

Scientific Methodologies: Equipped with sensors, the system collects objective and subjective data on the pelvic floor, enabling real-time monitoring and personalized treatment adjustments.

AI-Driven Capabilities: The clinician software portal utilizes collected data to benchmark pelvic health, monitor progress, and facilitate therapeutic interventions, enhancing the overall treatment experience.

Leadership Team

Hyivy Health is led by a team of dedicated professionals:

Rachel Bartholomew, Founder & CEO: Inspired by her personal health journey, she founded Hyivy Health to address unmet needs in women's pelvic health.

Kelly Foley, Chief Medical Officer: Oversees the medical aspects of product development and clinical trials.

Julianna Downes, VP of Engineering: Leads the engineering team in developing and refining the rehabilitation system.

Susan Stover, VP of Marketing: Manages marketing strategies to promote the company's mission and products.

Christie Eby, VP of Operations: Ensures efficient operational processes within the company.

Annabelle Chu, VP of Product Management: Oversees product development and lifecycle management.

Competitor Profile

Market Insights and Dynamics

The global pelvic health market is substantial, with millions of women experiencing pelvic floor disorders. The demand for innovative rehabilitation solutions is growing, driven by increased awareness and the need for effective, non-invasive treatments.

Competitor Analysis

Key competitors in the pelvic health rehabilitation space include:

Elvie: Offers a pelvic floor trainer that uses biofeedback to guide exercises.

Joylux: Provides devices that combine light therapy and thermal energy for pelvic floor strengthening.

Perifit: Develops Kegel exercisers with app integration for real-time feedback.

Hyivy Health differentiates itself by offering a multi-therapy device that not only provides treatment but also collects comprehensive data to inform personalized care plans.

Strategic Collaborations and Partnerships

Hyivy Health has established significant partnerships to advance its mission:

McMaster University: Collaborated on clinical trials focusing on endometriosis patients.

Grand River Hospital Regional Cancer Centre: Partnered for trials addressing rehabilitation needs of cancer patients.

These collaborations enhance the credibility and efficacy of Hyivy Health's solutions through rigorous clinical validation.

Operational Insights

Hyivy Health's strategic considerations include:

Market Position: By integrating multiple therapies and data analytics, Hyivy Health positions itself as a leader in holistic pelvic health rehabilitation.

Competitive Advantages: The combination of therapeutic interventions with real-time data collection and analysis offers a unique value proposition not currently available in the market.